Yahoo Finance

New ixlayer Survey Finds 73% of Pharma Leaders Are Running or Planning to Launch a DTP Program in the Next Year, and Half Say DTP Will Be Standard Practice Within Five Years

SAN FRANCISCO, Sept. 25, 2025 /PRNewswire/ -- ixlayer, a cloud-based healthtech platform, today announced the results of a new survey of pharma leaders conducted in partnership with the Digital Health ...
Pharmaceutical Commerce

The Metrics That Matter in Direct-to-Patient Strategies

Armstrong emphasizes that speed is a fundamental measure of success, and beyond timeliness, he notes that DTP programs offer ...
PharmiWeb

Tenpoint Therapeutics Ltd and PHIL Partner to Launch YUVEZZI™ Direct-to-Patient Cash Program to Make Novel Presbyopia Therapy More Accessible and Affordable

Tenpoint Therapeutics, a leading ophthalmic manufacturer, and PHIL Inc., an all-in-one digital hub and Direct-to-Patient platform, today announced the launch of a Direct-to-Patient (DTP) cash program ...
MediaPost

Pharma Ads Losing Effectiveness? Try Direct-To-Patient Programs

“Disconnected and fragmented” healthcare experiences -- such as prior authorization requirements and product accessibility issues -- are reducing the effectiveness of consumer ad spend, according to ...
Pharm Exec

TrumpRX Has a Blind Spot and It Can Redefine Patient Access

TrumpRx lowers drug prices but doesn't address diagnosis and care access barriers, limiting its impact on patient outcomes. Pharma must develop DTP programs integrating education, testing, and ...